Answers are grounded in this paper and cite their sources.
Antisynthetase syndrome (AS) is a rare autoimmune disorder whose treatment remains a challenge.1 In refractory cases, treatment escalation from glucocorticoids (GCs) and immunosuppressants to rituximab (RTX) is recommended.1
No takes yet. Share an insight, caveat, or question.
Campochiaro et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: